Advances in stem cell therapy for amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Regenerative Medicine
• Clinical Therapeutics

Background:

• Amyotrophic Lateral Sclerosis (ALS) is a progressive, incurable neurodegenerative disease affecting motoneurons.
• Cell-based therapies are being investigated as a potential treatment for ALS.
• Current pre-clinical and clinical studies have not yet yielded conclusive results.

Purpose of the Study:

• To conduct an integrated review of pre-clinical and clinical studies on cell-based therapies for ALS.
• To analyze the biological mechanisms of stem cell treatments in ALS models.
• To examine the methodologies and outcomes of existing clinical trials for ALS cell therapies.

Main Methods:

• Systematic review and analysis of published pre-clinical and clinical studies.
• Evaluation of stem cell biology relevant to ALS.
• Assessment of clinical trial designs, patient selection, and reported results.

Main Results:

• Individual studies show encouraging data, but stem cell therapies are not yet a reliable clinical option for ALS.
• Significant challenges remain in standardizing cell types, delivery methods, and patient stratification.
• The need for well-designed, randomized, and powered clinical trials is paramount.

Conclusions:

• Stem cell therapies for ALS require further development and validation through robust clinical trials.
• Comparative studies are essential to optimize donor cell characteristics, delivery routes, and patient selection.
• Establishing multidisciplinary expert networks is crucial for translating research findings into effective clinical practice for ALS.